Pharmaceutical composition for prophylaxis and/or treatment of corneal and conjunctival diseases or presbyopia containing stilbene compound as active ingredient
AssigneeKeio University
InventorsAkihiro HIGUCHI, Kazuo TSUBOTA, Kiyoshi FUKUHARA
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for prophylaxis and/or treatment of a corneal and conjunctival disease or presbyopia, the composition containing a compound represented by Formula (I), or a salt thereof or a prodrug thereof as an active ingredient, wherein m and n are each independently an integer of 0 to 5; m+n≧1; and each aromatic ring of the compound represented by Formula (I) may be substituted.
Claims13
A method for treating a corneal and conjunctival disease or presbyopia, comprising administering to a patient an effective amount of a compound represented by Formula (I), or a salt thereof or a prodrug thereof,
- wherein m and n are each independently an integer of 0 to 5;
- m+n≧1;
- and each aromatic ring of the compound represented by Formula (I) may be substituted, thereby treating the corneal and conjunctival disease or presbyopia in the patient.
(canceled)
A method for preventing a corneal and conjunctival disease or presbyopia, comprising administering to a patient an effective amount of a compound represented by Formula (I), or a salt thereof or a prodrug thereof,
- wherein m and n are each independently an integer of 0 to 5;
- m+n≧1;
- and each aromatic ring of the compound represented by Formula (I) may be substituted, thereby preventing the corneal and conjunctival disease or presbyopia in the patient.
A pharmaceutical composition comprising (a) a compound represented by Formula (I), or a salt thereof or a prodrug thereof,
- wherein m and n are each independently an integer of 0 to 5;
- m+n≧1;
- and each aromatic ring of the compound represented by Formula (I) may be substituted, and (b) a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.